Extended Durability in Exudative Retinal Diseases Using the Novel Intravitreal Anti-VEGF Antibody Biopolymer Conjugate KSI-301 1 Update from Phase 1b Study in Patients with wAMD, DME and RVO Mark R. Barakat, MD Retinal Consultants of Arizona Phoenix, AZ American Society of Retina Specialists 2020 July 10, 2020 Disclosures 2 ▪ Financial: AlconC Kodiak SciencesC AllegroC GenentechBC AllerganC NovartisBC AlimeraC NeuBaseS Bausch and LombC Ocular TherapeutixC Clearside BiomedicalC OxurionS EyePoint Pharmaceutic ...